What's new

Human medicines European public assessment report (EPAR): Stelara, ustekinumab, Date of authorisation: 15/01/2009, Revision: 50, Status: Authorised

Human medicines European public assessment report (EPAR): Stelara, ustekinumab, Date of authorisation: 15/01/2009, Revision: 50, Status: Authorised

Feb 25, 2025 - 15:55
 0
Human medicines European public assessment report (EPAR): Stelara, ustekinumab, Date of authorisation: 15/01/2009, Revision: 50, Status: Authorised
Human medicines European public assessment report (EPAR): Stelara, ustekinumab, Date of authorisation: 15/01/2009, Revision: 50, Status: Authorised
Read More

Tags:

Previous Article

Middle East Tourism in 2024: Who Saw The Most Growth?

Next Article

N.S.F. Cuts Raise Fears of a Reduced U.S. Presence in Polar Regions

Related Posts

Herbal medicinal product: Valerianae aetheroleumArray, C: ongoing call for scientific data

Herbal medicinal product: Valerianae aetheroleumArray, ...

Feb 14, 2025  0

EMEA-003421-PIP01-23

EMEA-003421-PIP01-23

Feb 13, 2025  0

Human medicines European public assessment report (EPAR): Penbraya, Meningococcal groups A, C, W, Y conjugate and group B vaccine (recombinant, adsorbed), Date of authorisation: 14/11/2024, Status: Withdrawn

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0